Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Nov;80(3):497–502. doi: 10.1111/j.1476-5381.1983.tb10721.x

Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.

R D Camp, A A Coutts, M W Greaves, A B Kay, M J Walport
PMCID: PMC2044991  PMID: 6315118

Abstract

The ability of intradermally injected leukotrienes C4 (LTC4), LTD4 and LTB4 to produce inflammatory changes in human skin alone and in combination with prostaglandin E2 (PGE2) has been investigated. LTC4 and D4 (0.012-0.38 nmol) caused dose-related erythema and wealing. No evidence of synergism between PGE2 and LTC4 or LTD4 was detected, although only single dose combinations were studied. LTB4 (0.15-1.5 nmol) caused areas of induration which persisted for more than 4 h and which showed perivascular neutrophil infiltrates on histological examination. Only slight synergism between PGE2 and LTB4 was found. It was concluded that these pro-inflammatory properties of LTC4, LTD4 and LTB4 are consistent with their proposed roles as mediators of inflammation in the skin and other tissues.

Full text

PDF
497

Images in this article

500Figure 3
on p.500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bisgaard H., Kristensen J., Søndergaard J. The effect of leukotriene C4 and D4 on cutaneous blood flow in humans. Prostaglandins. 1982 Jun;23(6):797–801. doi: 10.1016/0090-6980(82)90124-1. [DOI] [PubMed] [Google Scholar]
  2. Borgeat P., Picard S., Vallerand P., Sirois P. Transformation of arachidonic acid in leukocytes. Isolation and structural analysis of a novel dihydroxy derivative. Prostaglandins Med. 1981 Jun;6(6):557–570. doi: 10.1016/0161-4630(81)90117-8. [DOI] [PubMed] [Google Scholar]
  3. Borgeat P., Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci U S A. 1979 May;76(5):2148–2152. doi: 10.1073/pnas.76.5.2148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brain S. D., Camp R. D., Dowd P. M., Black A. K., Woollard P. M., Mallet A. I., Greaves M. W. Psoriasis and leukotriene B4. Lancet. 1982 Oct 2;2(8301):762–763. doi: 10.1016/s0140-6736(82)90939-4. [DOI] [PubMed] [Google Scholar]
  5. Camp R. D. Prostaglandins, hydroxy fatty acids, leukotrienes and inflammation of the skin. Clin Exp Dermatol. 1982 Jul;7(4):435–444. doi: 10.1111/j.1365-2230.1982.tb02453.x. [DOI] [PubMed] [Google Scholar]
  6. Davidson E. M., Rae S. A., Smith M. J. Leukotriene B4 in synovial fluid. J Pharm Pharmacol. 1982 Jun;34(6):410–410. doi: 10.1111/j.2042-7158.1982.tb04745.x. [DOI] [PubMed] [Google Scholar]
  7. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  8. Klickstein L. B., Shapleigh C., Goetzl E. J. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest. 1980 Nov;66(5):1166–1170. doi: 10.1172/JCI109947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Marks R., Greaves M. W. Vascular reactions to histamine and compound 48/80 in human skin: suppression by a histamine H2-receptor blocking agent. Br J Clin Pharmacol. 1977 Jun;4(3):367–369. doi: 10.1111/j.1365-2125.1977.tb00725.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nagy L., Lee T. H., Goetzl E. J., Pickett W. C., Kay A. B. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol. 1982 Mar;47(3):541–547. [PMC free article] [PubMed] [Google Scholar]
  11. Palmer R. M., Stepney R. J., Higgs G. A., Eakins K. E. Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species. Prostaglandins. 1980 Aug;20(2):411–418. doi: 10.1016/s0090-6980(80)80058-x. [DOI] [PubMed] [Google Scholar]
  12. Peck M. J., Piper P. J., Williams T. J. The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins. 1981 Feb;21(2):315–321. doi: 10.1016/0090-6980(81)90149-0. [DOI] [PubMed] [Google Scholar]
  13. Samuelsson B., Hammarström S. Nomenclature for leukotrienes. Prostaglandins. 1980 May;19(5):645–648. doi: 10.1016/0090-6980(80)90099-4. [DOI] [PubMed] [Google Scholar]
  14. Sirois P., Borgeat P. From slow reacting substance of anaphylaxis (SRS-A) to leukotriene D4 (LTD4). Int J Immunopharmacol. 1980;2(4):281–293. doi: 10.1016/0192-0561(80)90028-4. [DOI] [PubMed] [Google Scholar]
  15. Sirois P., Roy S., Borgeat P., Picard S., Corey E. J. Structural requirement for the action of leukotriene B4 on the guinea-pig lung:importance of double bond geometry in the 6, 8, 10-triene unit. Biochem Biophys Res Commun. 1981 Mar 31;99(2):385–390. doi: 10.1016/0006-291x(81)91757-5. [DOI] [PubMed] [Google Scholar]
  16. Soter N. A., Lewis R. A., Corey E. J., Austen K. F. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol. 1983 Feb;80(2):115–119. doi: 10.1111/1523-1747.ep12531738. [DOI] [PubMed] [Google Scholar]
  17. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES